Skip to main content

Tarsus Pharmaceuticals, Inc 10-Q for FY2021 Q1

Tarsus Pharmaceuticals, Inc. (TARS)

10-Q 2021-05-11 For: 2021-03-31
View Original
Added on April 04, 2026

About this 10-Q

Tarsus Pharmaceuticals, Inc filed this 10-Q on May 11, 2021, covering the quarter ended March 31, 2021 (FY2021 Q1).

Headline figures

Quarter ended March 31, 2021, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$33.43M
compared with $0 a year earlier
Net income
$10.38M
compared with a net loss of $1.96M a year earlier
Diluted EPS
$0.47
compared with -$0.74 a year earlier